Suscripción a Biblioteca: Guest
International Journal of Medicinal Mushrooms

Publicado 12 números por año

ISSN Imprimir: 1521-9437

ISSN En Línea: 1940-4344

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.2 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 1.4 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00066 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.34 SJR: 0.274 SNIP: 0.41 CiteScore™:: 2.8 H-Index: 37

Indexed in

Can Bioactive Polysaccharides and Proteo-Polysaccharides from Medicinal Mushrooms Benefit Women with Malignant Breast Tumors?

Volumen 7, Edición 3, 2005, 391 pages
DOI: 10.1615/IntJMedMushrooms.v7.i3.390
Get accessDownload

SINOPSIS

In view of the staggering statistics of women, especially menopausal women, who are afflicted with malignant breast tumors, there is an urgent need to seek effective measures to combat such sweeping health problems. The World Health Organization (WHO) predicts that more than 1.2 million women worldwide may develop breast cancer this year. In the United States of America alone, 1,370,910 new cases of breast cancer may be documented in 2005, estimated by the American Cancer Society. One in eight women may experience breast cancer in her lifetime.
Prominent species of medicinal mushrooms have a long-standing history of being used for health benefits, including antitumor effects, particularly in China, Japan, and Russia. We are examining bioactive polysaccharides and proteo-polysaccharides from selected species of medicinal mushrooms, in adjunct use with conventional cancer treatment. Our interest is in center therapy with immunoceuticals, immunomodulating components from medicinal mushrooms, which are effective by oral intake. Bioactive polysaccharides and proteo-polysaccharides in the category of immunoceuticals from Ganoderma lucidum (W.Curt.:Fr.) Lloyd, Grifola frondosa (Dicks.: Fr.) S.F.Gray, and Trametes versicolor (L.:Fr.) Pilat will be examined for their potential to alleviate the devastating side effects of conventional cancer treatments, such as presurgery hormonal therapy or chemotherapy to shrink the size of tumor, surgery, as well as postsurgery radiation therapy, chemotherapy, or hormonal therapy. Exciting initial results of a case study of a stage II breast cancer patient who uses bioactive polysaccharides from medicinal mushrooms during chemotherapy will be reported.
The project is designed as a forum to raise questions, evoke discussions, and seek evidence-based information. The intended audience is laymen at large and medical professionals, who are currently in practice. Sample questions in brainstorming include cell-receptor for glucans, autoimmune diseases, antioxidants, use of vitamin C, potential cross-drug interaction, toxicity, safety in use, contraindications, who should avoid using such components, and how can breast cancer patients benefit.
To provide bioactive mushroom polysaccharide and proteo-polysaccharide in adjunct use to conventional cancer treatment is a vitally important area, to which medicinal mushroom science and industry can contribute. More quality large-scale longitudinal clinical studies as well as case studies with specific information are encouraged. Attention is called to mushroom growers to produce high-standard, organically grown mushrooms as a source of effective polysaccharides and proteo-polysaccharides with efficacy for cancer and other uses.

Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones Precios y Políticas de Suscripcione Begell House Contáctenos Language English 中文 Русский Português German French Spain